Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7396 p441
15 April 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

· PSNC
· Antibiotics
· Packaging
· Medicines use reviews
· Smoking cessation
· Statistics
· Statins
· Drug misuse
· Agenda for Change
· Palliative care
· The Society (2)


Letters to the Editor

Drug misuse

Clarification regarding certificate course

From Mrs D. K. Roberts, FRPharmS

Best practice guidance, produced by the National Treatment Agency for Substance Misuse, on the commissioning of pharmaceutical services for drug misusers, is most welcome and timely (PJ, 1 April, p378).

I would, however, welcome the opportunity to clarify part of the information included in the feature. I refer to the Royal College of General Practitioners certificate in the management of drug misuse that was completed by pharmacists taking part in the Lewisham local pharmaceutical services pilot scheme.

The open learning pack — “Opiate treatment: supporting pharmacists for improved patient care” from the Centre for Pharmacy Postgraduate Education is not an integral part of the RCGP certificate as suggested in the news feature. At the time that the Lewisham pharmacists undertook the RCGP certificate, pharmacists wishing to undertake part 2 of the RCGP certificate were able to claim exemption from part 1 provided that they were able to prove recent completion of the CPPE’s open learning pack.

It is expected that e-learning modules for part 1 of the RCGP certificate will be accessible to pharmacists, nurses and GPs later this year. From then on pharmacists wishing to undertake part 2 of the RCGP certificate will have the choice of either completing the part 1 of the RCGP certificate online, or claiming exemption by providing proof of completion of the new CPPE open learning package on drug misuse.

Kay Roberts
Lead Pharmacist
Royal College of General Practitioners’ Substance Misuse Unit

Send your letter to The Editor

Previous Topic (Statins)
Next Topic (Agenda for Change)

Back to Top


©The Pharmaceutical Journal